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1Introduction
Multidisciplinary team (MDT) work has become the stand-
ard in cancer care in the last decades as diagnostic and 
treatment options for various cancers grew [1]. The impor-
tance of multidisciplinarity further increased due to a shift 
from disease- focused management to a patient- centered 
approach. The European Partnership for Action Against 
Cancer (EPAAC), launched by the European Commission 
in 2009, therefore identified multidisciplinary care as a 
key element in cancer care [2]. Evidence on the impact 
of MDT- work on clinical outcomes is sparse, partly due 
to difficulties in relating procedural- and organizational 
changes to the various possible benefits [3]. A recent study 
in 13,722 breast cancer patients showed that improved 
multidisciplinary care was associated with improved sur-
vival and reduced variation in survival [4]. While MDT- 
work may seem self- evident for specialized cancer centers 
or university hospitals, it is a more recent development 
and an organizational challenge for general hospitals [5].
In the Netherlands, regional Comprehensive Cancer 
Organisations were established in the eighties to dissemi-
nate specialized knowledge on cancer diagnosis and treat-
ment and to improve service provision without having 
a treatment function themselves. They formed networks 
of health care professionals with the aim to improve 
cancer care and outcomes through research, guideline 
development, and implementation, knowledge exchange 
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Abstract
External peer review was introduced in general hospitals in the Netherlands in 
1994 to assess and improve the multidisciplinary team approach in cancer care. 
This paper aims to explore the value, perceived impact, and (future) role of 
external peer review in cancer care. Semistructured interviews were held with 
clinicians, oncology nurses, and managers from fifteen general hospitals that 
participated in three rounds of peer review over a period of 16 years. Inter-
viewees reflected on the goals and expectations, experiences, perceived impact, 
and future role of external peer review. Transcriptions of the interviews were 
coded to discover recurrent themes. Improving clinical care and organization 
were the main motives for participation. Positive impact was perceived on mul-
tiple aspects of care such as shared responsibilities, internal prioritization of 
cancer care, improved communication, and a clear structure and position of 
cancer care within general hospitals. Establishing a direct relationship between 
the external peer review and organizational or clinical impact proved to be 
difficult. Criticism was raised on the content of the program being too theoreti-
cal and organization- focussed after three rounds. According to most stakeholders, 
external peer review can improve multidisciplinary team work in cancer care; 
however, the acceptance is threatened by a perceived disbalance between effort 
and visible clinical impact. Leaner and more clinically focused programs are 
needed to keep repeated peer reviews challenging and worthwhile.
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and organizational improvement, for instance, by pro-
moting multidisciplinary care. The Comprehensive Cancer 
Organisation in the North of the Netherlands introduced 
an external peer review program in 1994 to review the 
multidisciplinary organization of cancer care in hospitals 
and provide relevant feedback for further improvement. 
The program focussed on the organization of cancer care 
within the general hospital setting. Over time, it evolved 
and also paid attention to patient centeredness and impor-
tant (inter)national trends such as centralization. The 
primary focus remained on the organization of cancer 
care and the functioning of the multidisciplinary teams. 
Policies were reviewed but not checked for individual 
cases, such as compliance with policies for adjuvant 
chemotherapy or psychosocial care. Through self- reviews, 
site visits and on- site interviews the organization of cancer 
care in a hospital is evaluated and recommendations for 
improvement are given. Reviewers are specially trained 
clinicians and nurses from other hospitals. Hospitals par-
ticipate voluntarily and are advised to participate in cycles 
of 4–5 years to ensure continuous cycles of quality 
improvement. Annex 1 gives more detailed information 
on the external peer review program. Similar programs 
have been introduced in other countries. In England, for 
example, National Cancer Peer Review (NCPR) was intro-
duced as part of the National Cancer Programme in 2004, 
after a first round of peer review was conducted at a 
regional level in 2001 [6]. The English program focuses 
on performance for specific tumor groups, whereas the 
Dutch program primarily targets the multidisciplinary 
cancer care organization in hospitals as a whole.
Until now, we have published two peer- reviewed studies 
on the effects of the Dutch peer review program for mul-
tidisciplinary cancer care [7, 8]. Some positive effects were 
found on multidisciplinary colorectal cancer treatment but 
the outcomes needed to be interpreted with care due to 
possible confounding factors such as patient case- mix and 
regional differences [7]. No added value was found on 
multidisciplinary treatment of breast cancer, as regional 
factors seemed to exert a stronger effect on treatment 
patterns than hospital participation in external peer review 
[8]. In general, (international) evidence on the effects of 
peer review on cancer care is sparse. In lung cancer, peer 
review was successful in stimulating quality improvement 
activities but improvements in treatment rates and patient 
experiences were small [9]. Outside the field of cancer 
care, two studies report on the one- and three- year evalu-
ation of peer review for chronic obstructive pulmonary 
disease in the UK [10, 11]. Findings after 3 years indicated 
an association with improved quality of care, service deliv-
ery, and changes that promote quality improvement [11]. 
The one- year evaluation revealed no differences showing 
that changes need a longer period to occur [10].
While evidence on external peer review is sparse, physi-
cians worldwide are increasingly confronted with programs 
such as external peer review and accreditation. In this 
qualitative study, we aim to explore the role and impact 
of external peer review for multidisciplinary cancer care 
in the general hospital setting. In interviews with stake-
holders, we evaluated the value, perceived impact and 
(future) role of external peer review in cancer care.
Material and Methods
Semistructured interviews were conducted with stakehold-
ers from general hospitals from two regions in the 
Netherlands that participated three times between 1994–
2010 (North and Rotterdam region).The hospitals in these 
two regions have the longest experience in the program 
with three cycles of peer review in our study period. We 
excluded hospitals that merged in the study period, as 
this made it hard to reflect on recommendations and the 
impact of the program. From the two regions, all 26 
qualifying hospitals were invited to participate in our study. 
Per hospital, we requested to interview a clinician involved 
in the treatment of cancer patients, an oncology nurse, 
and a representative from the board of directors or man-
agement. We aimed to interview at least two stakeholders 
per hospital. The following inclusion criteria were applied: 
(1) the interviewee was required to have participated in 
at least one peer review visit (preferably also involved in 
preparations for the program); (2) oncology nurses should 
have coordinating/organizational tasks; (3) the management 
representative had to be involved with cancer care man-
agement in the hospital. Participation in the interviews 
was voluntary and participants were not reimbursed.
The telephonic interviews were conducted in Dutch 
from May to October 2012 by the principal investigator 
(M. K). Participants were informed about the purpose of 
the study and how the data would be used. The interviews 
followed a fixed scheme. First, the motivation for par-
ticipation was discussed, followed by the experiences with 
the program. This was discussed according to the chrono-
logical phases of the program: self- review phase, the actual 
site visit and the aftermath. Consequently, the impact 
was discussed and examples of program effects were asked. 
To conclude, views on the role of the program in the 
future and possible improvements were asked. A list of 
general questions covering these topics was used. An 
overview of the main interview topics, questions, and the 
rationale behind the questions is presented in Table 1.
All interviews were recorded and transcribed verbatim, 
using word processing software by the principal investiga-
tor (M. K). All data were anonymized and interviewees 
were guaranteed that data would not be shared with the 
third party, allowing them to speak freely. The transcripts 
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were analyzed by using ATLAS.ti software (version 7, www.
atlasti.com). Using an inductive approach (organizing the 
data based upon common patterns or themes), the entire 
transcripts were coded. Answers were given a distinct code 
to get an overall impression of the results from the inter-
views. Relevant citations were selected as illustration per 
interview topic. The results and citations were discussed 
with other investigators (W. V. H, S. S). Despite the quali-
tative nature of this study, answers on specific questions, 
such as what the goals were to participate could be quan-
titatively analyzed. In these cases, frequencies of answers 
were used to determine their relative importance.
Results
Study population
Fifteen out of the twenty- six invited hospitals participated 
in our study. Two hospitals reacted that they were either 
not able or not willing to invest their time in interviews, 
the rest did not reply to our invitation and gave no reason 
for not participating. In our study population of fifteen 
hospitals, it was not possible to interview two stakeholders 
in two hospitals; in one hospital, we could only interview 
a medical specialist and in another hospital, we only inter-
viewed an oncology nurse. Additionally, in one hospital there 
was not a nurse available with sufficient experience with 
the program to participate. We could only interview four 
managers that met our criteria of being personally involved 
in at least one external peer review and involvement in 
cancer care (partly due to high management turnover). In 
total, data from 15 hospitals and 31 interviews were analyzed: 
14 physicians (eight medical oncologists, four surgeons, one 
pulmonary physician, and one gynecologist), 13 oncology 
nurses, and four management representatives.
Interview findings
Motivation
The motivation to participate could be coded into ten 
distinct codes or ‘buckets’ as can be seen in Table 2. We 
further categorized these codes into four main ‘themes’. 
The most frequently mentioned goal for participating in 
the program was to obtain feedback on the quality of 
organization and processes (coded 21 times). Clinical qual-
ity improvement is mentioned by a majority of interviewees 
(N = 19) as a goal for participation, even though the 
program foremost has an organizational focus. Differences 
between physicians and nurses are seen in the positioning 
of cancer care which is an important goal especially for 
physicians (physicians: eight, nursing staff: two). By the 
position of cancer care, the interviewees mean that cancer 
care was given priority amongst a hospital wide range of 
services and became the joined responsibility for physi-
cians, nursing staff, and management. This is illustrated 
by the next quote:
As a medical oncologist you are not the only one in 
the web of physicians surrounding a patient. In every 
single case, a lot of physicians should communicate and 
cooperate. Sometimes one physician thinks this is more 
important than another. By participating in the program, 
you hope that attention is raised for everyone to see this 
necessity. [Oncologist]
Program experiences
The first phase of the external peer review, the self- review 
phase, forced stakeholders to review the organization and 
cooperation within their own hospital. Nineteen respondents 
stated that self- review through stating compliance to lists 
of organizational standards is a good method to discover 
Table 1. Overview of interview themes with examples of questions and the rationale behind the themes and questions. In this table only the main 
‘opening questions’ are presented.
Interview topics Main/opening question(s) Rationale
Goals What are your goals for participation in this program? Explore if the incentive is organizational improve-
ment, quality improvement or both
Experiences 
(program 
evaluation)
What are your experiences with the self- assessment phase of the 
program and what was its value?
What are your experiences with the actual site visit, what was its value 
and what was the added value after the self- assessment?
What is your opinion about the end- rapport, did it reflect the state of 
cancer care in your hospital?
Experiences with the different program phases gives 
information on what the most important parts of 
external peer review programs are and when 
changes occur
Impact In which areas did you experience a program impact? 
Can you give examples of program effects?
Answers give insights in how external peer review 
influences organization and care and which aspects 
of care are affected
Future If the program would remain as it is now, would you participate again? 
How can the program be improved?
Does a program retain its value after three participa-
tions or does it need changes?
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weak points in their organization. It was said that changes 
already occurred in this preparation phase as existing poli-
cies were revised and corrected if necessary. Interestingly, 
all of these nineteen interviewees claim that the weaknesses 
were not totally unknown beforehand. The self- review phase 
was also the most criticized part of the program. All inter-
viewees answered that the investments (time and effort) 
were high. The questionnaires were criticized for being too 
theoretical, insufficiently suited for their individual situation 
and containing too many irrelevant and ‘obvious’ questions. 
It was mentioned three times that difficulties in answering 
questions sometimes resulted in giving ‘desired’ answers.
The actual site visit by peers, is valued highly, 20 
respondents mentioned that this is the most important 
part of the program. Especially the dialog and opportunity 
to explain how they work was appreciated instead of only 
stating their compliance to a theoretical framework. Also, 
misinterpretations of answers given in the self- assessment 
could be corrected. Almost all interviewees (N = 29) 
stressed the importance of a committee consisting of peers 
because of the mutual understanding of problems that 
hospitals are faced with. Eighteen participants think that 
the composition of the review committee (three medical 
specialists and one oncology nurse) does not need to be 
altered. Suggested changes to the committee were to add 
an extra oncology nurse (N = 2), a manager (N = 2) or 
a professional from the psychosocial field (N = 6). The 
rest of the interviewees had no opinion on this matter.
The final phase of the program starts with the end- 
report based on the self- assessment and findings of the 
site visit. The recommendations in the reports are generally 
regarded as a good reflection of the weaknesses and 
improvement points of the organization. All respondents 
answered that the recommendations are used in the cancer 
policy plans of their hospitals for the upcoming years. 
The reports are used to strengthen the position of the 
oncology services in negotiations with the board of direc-
tors and medical staff.
Perceived impact and examples of program effects
In order to gain more understanding of how the program 
impacted cancer care in hospitals, every stakeholder was 
asked to give examples of important effects of the program 
(if there were any). We coded the aspects of care that were 
influenced by the program. We found ten aspects of cancer 
care on which the program had a perceived impact. They 
are mentioned in Table 3 with the examples that were 
given by the interviewees. The frequencies of the answers 
give a sense of importance but because we asked for exam-
ples we did not use the frequencies to determine which 
aspect of care is most influenced by the program. Not 
mentioning an example does not mean that the program 
did not impact that aspect of care in their hospital.
A perceived impact on the position of cancer care within 
the hospital organization is expressed nine times. It was 
also mentioned ten times as goal for participation (Table 2). 
This seems to work two ways: as mentioned earlier, the 
participation itself creates attention and involvement. 
Secondly, the other examples of perceived impact also 
enforce prioritization of cancer care. For example, a per-
ceived impact on the (role of the) oncology committee 
was expressed 21 times in total. Also, according to a total 
of nine interviewees the role of the committee within the 
hospital and policy making was formalized. The formation 
of multidisciplinary oncology committees with representa-
tives from all disciplines that treat cancer patients was 
stimulated, especially in the first review rounds (most of 
the committees were small and not all disciplines were 
represented). This created an official structure within 
Table 2. Number of times a goal for participating in the peer review program was mentioned by different stakeholders. Interviewees could have had 
more than one goal.
Goals/incentive for 
participation (themes)
Goals mentioned by interviewees Physicians 
(N = 14)
Nurses 
(N = 13)
Management 
(N = 4)
Total 
(N = 31)
External motivation Transparency 1 4 0 5
Obligation 1 2 2 4
See what external experts find important in cancer care 0 4 0 4
Organization of care Quality test of organization and processes (see how well 
you are doing)
9 10 2 21
Positioning of cancer care in the hospital (priority for 
management and/or physicians)
8 2 0 10
Reveal organizational weaknesses (blind- spots) 0 4 0 4
Receive recommendations for improvement 2 2 2 6
Re- evaluate existing patterns in cooperation and 
communication
1 1 0 2
Clinical cancer care Quality improvement of clinical cancer care 9 7 3 19
Future perspectives Getting ready for changes in the future 1 0 1 2
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hospitals to advocate the interests of medical personnel 
and cancer patients in structural meetings with the board 
of directors and medical staff. Because the oncology com-
mittee was required to consist of representatives from all 
specialisms that treat cancer patients, ‘smaller specialisms’ 
like gynecologists and urologists became more involved 
which improved communication. There was also a more 
general perceived impact on the cooperation between physi-
cians and between physicians and nursing staff (N = 4). 
Concerning clinical care, most impact was experienced on 
the multidisciplinary patient care meetings. Fourteen inter-
viewees mentioned an example of impact on these meetings. 
Due to the recommendations, multidisciplinary patient care 
meetings were professionalized, protocols were developed 
on which patients should be discussed in these meetings 
and reporting was standardized. The program required 
weekly meetings where every newly diagnosed cancer patient 
was discussed in the multidisciplinary team to improve 
shared decision- making. Less frequently mentioned examples 
of program impact concern impact on structure, delivery 
of care, psychosocial care, nursing staff, referral policies, 
and future perspectives. These include increased numbers 
of staff, better integration of psychosocial care and advice 
on the introduction of integrated care pathways (Table 3).
Interviewees found it difficult to single out the effects 
of the program. Investments in extra oncology nurses can 
be contributed to clear recommendations in the final 
reports of the program, but other (clinical) effects of the 
program do not stand on their own. This is illustrated 
in the next citation:
Every patient has an individual case- manager now. That 
would probably have been established anyway, but because 
of the recommendation of the program it might have 
been introduced earlier. Yes, I think that had an impact. 
Another example is the multidisciplinary patient care 
meeting. They needed to be held more often and larger 
groups of patients needed to be discussed. I think that 
this would have been realized anyway because of the 
national guidelines and not only because of the program, 
but it certainly influenced it. [Oncology nurse]
Table 3. Examples of effects of the external peer review programs as mentioned by interviewees (N = 31) grouped per theme.
Theme Examples of impact given by the interviewees
Position of cancer care in hospital 
Oncology committee
• Cancer care became a priority (N = 9)
• Large committees were formed with representatives from all disciplines treating cancer patients (N = 9)
• role of committee was officially established in hospital organization (N = 2)
• Committee got responsibility for policy making (N = 5)
• Functioning of committee improved (N = 3)
• Structural meetings were organized with board of directors and medical staff (N = 2) 
Cooperation • Involvement of “smaller” disciplines such as gynecologists and urologists (N = 6) 
• Improved communication between specialists and between specialists and nursing staff (N = 4)
• Improved communication with general practitioners (N = 1) 
 
Multidisciplinary patient care 
meetings
• Involvement smaller disciplines in the meetings (N = 3)
• Protocols on which patients have to be discussed (N = 14)
• Uniformity of reporting (N = 1)
 
Structure • Increased number of nursing staff (N = 6)
• Investments in ICT (N = 1)
 
Delivery of care • Advice on the introduction of integrated care pathways (N = 2)
• Concentration of chemotherapy administration within the hospital (N = 1)
 
Referral policies • Referral policies were made for rare tumors (N = 1)
• Official agreements were signed with other hospitals on which patients to treat and which to refer for 
further treatment. (N = 3)
 
Nursing staff • Introduction of specialized oncology nurses (N = 6)
• Education (N = 2)
 
Psychosocial care • Increased number of psychosocial staff (N = 6)
• Clarity on the role and positioning of psychosocial staff (N = 1)
• Introduction psychosocial protocols (N = 1)
 
Readiness for change • Organization is better prepared to adapt to future changes (N = 4) 
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Future role and improvements of the program
All hospitals in our study population participated in three 
review rounds. The program started with a strong focus 
on basic organizational requirements and evolved from 
there with more emphasis on professional quality and 
care pathway organization. The organizational focus 
remained to be a source of frustration. Twenty interviewees 
expressed their concerns on having to repeat all the organi-
zational items in the self- review and site visit in a fourth 
participation round. As a result, only 12 persons would 
still find a fourth participation worthwhile without major 
changes in the program. This suggests that a mismatch 
between the investments and experienced benefits is a 
potential pitfall for the program.
Suggestions for improvement that were given are as 
follows:
1 move beyond the basic organizational conditions and 
focus on the actual delivery of care
2 decrease the time investments needed for 
self-assessment.
3 more emphasis on current and future requirements in 
oncology.
4 focus on one or two specific types of cancer.
5 give hospitals the opportunity to indicate on which parts 
of the care process they would like to receive in-depth 
feedback.
6 strengthen the patients’ perspective compared to the 
organizational perspective.
Opinions varied whether the focus of the program should 
remain on the entire cancer care organization or on spe-
cific types of cancer. Advantages mentioned of a tumor- 
specific program were a better focus on actual care, less 
time- consuming preparations, and the possibility to assign 
clinical experts as reviewers.
Disadvantages of a tumor- specific program were also 
mentioned. There are already multiple organizations that 
have developed registrations and clinical audits for specific 
diseases. Because of this, there is a risk of an overkill of 
external assessment programs. Other interviewees mentioned 
that the necessity to look at the entire organization does 
not change; weak points in the organization mostly concern 
aspects of cooperation and communication, which can be 
easier tackled through an organization focussed program.
Discussion
It can be carefully concluded that the external peer review 
program for multidisciplinary care in the Netherlands had 
a perceived positive impact on several aspects of cancer 
care. Most frequently mentioned were the internal 
positioning of cancer care, formation and role of oncol-
ogy committee and multidisciplinary team meetings. Part 
of the experienced impact could be attributed directly to 
the program based on recommendations in the final reports. 
Interviewees were hesitant to attribute more clinically 
oriented effects to the program alone, as many factors 
can be of influence. Although the program has an organi-
zational focus, improvement of clinical care is mentioned 
as a motivation to participate almost as often as organi-
zational improvement. Criticism was also raised, particu-
larly on the repeated organizational focus and missing 
links with clinical care (most outspokenly in the self- review 
phase). Nineteen interviewees mentioned that while the 
self- review uncovers organizational weak spots, they were 
not entirely unknown beforehand. It therefore seems that 
the value lies in directing attention to these weak spots. 
The actual site visits were regarded as the most important 
part of the program because of the dialog that occurs 
with their peers from the review committee.
It is difficult to prove a direct impact of external qual-
ity improvement programs. A previous mixed- method 
study on accreditation also struggled to answer the ques-
tion. Performance on accreditation was found to be an 
accurate reflection of contextual organizational factors 
believed to be important in enabling or inhibiting quality 
of care and continuous quality improvement [12]. A French 
study on the impact of accreditation used a hypothetical 
model in which accreditation is seen as an agent of change 
[13]. These studies complement our findings that external 
peer review is one of multiple factors that initiates change 
and contributes to a better organization that can lead to 
quality improvement.
The external peer review program for multidisciplinary 
cancer care was introduced to strengthen and support 
the (introduction of) multidisciplinary team work. There 
are two main categories of barriers to effective cancer 
care coordination. Firstly, those barriers that are a result 
of an ineffective team (recognition of health professional 
roles and responsibilities, transition of care, inadequate 
communication), and secondly barriers that are the result 
of inadequate resources, including managing scarce 
resources and inequitable access to health services [5]. 
Our results especially show a perceived program impact 
on those barriers resulting from ineffective team work. 
Examples of the perceived impact revealed a transferral 
of responsibilities from individual physicians to multidis-
ciplinary teams consisting of physicians, nursing and sup-
porting personnel. This lead to prioritization of cancer 
care, improved communication, and a central position of 
cancer care within general hospitals.
Contrary to our finding that the site visit is the most 
valued part of the program, previous research identified 
the self- review as the most important [13]. This might 
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be due to the fact that the review committee consists of 
peers, which creates mutual understanding. It also implies 
that stakeholders value an approach that is not overly 
focussed on standards. Touati and Pomey described this 
earlier and drew parallels between accreditation and a 
management model of “commitment based management” 
instead of “control based management” [14]. Leaving a 
philosophy of control and adapting a philosophy of com-
mitment provides greater room for autonomy and creativity 
of the reviewed hospital and stakeholders. This approach 
to quality management requires a challenging balance of 
improvement dynamics with standardization and assur-
ance, but can be used to prevent the perception of external 
quality assessment programs as coercive tools of over- 
standardization [15]. The disbalance between effort and 
effect threatens the legitimacy of the program. Possibilities 
for improvement of the program are mainly to move 
away from basic organizational requirements after a first 
or second round and focus more on actual clinical care. 
This can be achieved by making better use of the infor-
mation from previous peer reviews. When it has been 
established that the basic organizational requirements were 
met, new peer reviews can pay attention to other aspects 
of care. This might create leaner and more flexible 
programs.
Our study has several limitations. There will always be 
a certain degree of interpretation when working with 
qualitative data. We tried to minimize this by coding the 
transcripts with specialized software. The frequencies are 
mentioned to give a sense of importance. We were cau-
tious to use this to make statements on the impact of 
the program. The frequency counts in Table 2 and 3 are 
unbalanced which makes it difficult to draw firm conclu-
sions. It does give a general overview of motivation and 
perceived impact. Although we interviewed representatives 
from 15 different hospitals, a larger study population might 
have revealed more details (although we experienced a 
considerable degree of saturation). We could only interview 
four management representatives due to a high manage-
ment turnover and because managers were not always 
involved in the process before the actual site visit. Eleven 
hospitals that were invited did not participate which might 
have resulted in a selection bias. The hospitals were invited 
because their regions were the first to implement the 
program. Therefore, our findings only represent hospitals 
with multiple participations in the program. The interviews 
were not done after each peer review but retrospective 
after three cycles of review which might cause a fading 
of memories. Hospitals that participate for the first time 
might find it more useful to focus on more basic organi-
zational conditions. However, our research is unique in 
investigating organizations with multiple participations and 
our results show a decreasing acceptance for external peer 
review if a program keeps focussing on organizational 
standards.
Conclusion
Organizational external peer review can be an appropriate 
method for general hospitals to improve multidisciplinary 
team work in cancer care. In general hospitals, it can 
help in the internal positioning of cancer care and to 
improve structures and processes that encourage multi-
disciplinary team work. Our findings suggest that, con-
cerning actual clinical care, external peer review has an 
indirect impact by influencing the multidisciplinary patients 
meetings, numbers of staff etc. The acceptance of a pro-
gram that primarily focuses on organizational requirements 
decreases after multiple participations. As a majority of 
interviewees participate to improve both organizational 
and clinical care, we argue that moving from an organi-
zational focus to clinical cancer services in future par-
ticipations can keep external peer review worthwhile and 
challenging.
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